Orthocell Limited (ASX:OCC) Submits FDA Application for Remplir™
Orthocell submits its FDA application for Remplir™, targeting the US nerve repair market, with clearance expected by April 2025.
Tag: Investor Relations
Imugene Limited (ASX:IMU) Confirms $11 Million R&D Tax Refund
Imugene Limited (ASX:IMU) secures $11 million R&D tax refund to advance its immuno-oncology therapies.
EBR Systems, Inc. (ASX:EBR) Schedules FDA Pre-Approval Inspection
EBR Systems, Inc. announces a scheduled FDA Pre-Approval Inspection for its wireless cardiac pacing device, a pivotal step in regulatory progress.
Clarity Pharmaceuticals (ASX:CU6) Expands Radiopharmaceutical Pipeline
Clarity Pharmaceuticals (ASX:CU6) unveils a novel radiopharmaceutical, SAR-bisFAP, enhancing cancer diagnosis and treatment potential.
Carbonxt Group Limited (ASX:CG1) Achieves Mechanical Completion of Kentucky Plant
Carbonxt Group Limited (ASX:CG1) has achieved mechanical completion of its Kentucky plant, enhancing its capacity to meet activated carbon market demand.
Adisyn Ltd (ASX:AI1) Completes Due Diligence for 2D Generation Acquisition
Adisyn Ltd has completed due diligence for acquiring 2D Generation, enhancing its semiconductor technology capabilities for the generative AI market.
MetalsTech Limited (ASX:MTC) Advances Sturec Gold Mine Activities
MetalsTech Limited (ASX:MTC) provides updates on the Sturec Gold Mine’s operations, maintenance, and identified mineralisation potential.
MONEYME Limited (ASX:MME) Secures A$125 Million Funding Facility
MONEYME secures a strategic A$125 million funding facility with iPartners, enhancing growth and refinancing existing debt.
Triangle Energy (Global) Limited (ASX:TEG) Announces Cliff Head Sale Update
Triangle Energy (ASX:TEG) reports the first payment for the Cliff Head project sale remains unpaid, creating immediate financial implications.
Skin Elements Limited (ASX:SKN) Initiates Trading Halt
Skin Elements Limited (ASX:SKN) has requested a trading halt pending significant announcements regarding a court application and capital raising.